+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antiemetic Efficacy of Tropisetron in Patients Failing Previous Antiemetic Therapy



Antiemetic Efficacy of Tropisetron in Patients Failing Previous Antiemetic Therapy



Oncology 52(5): 427-431




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067792220

Download citation: RISBibTeXText

DOI: 10.1159/000227502


Related references

Antiemetic efficacy of tropisetron in patients failing previous antiemetic therapy. Oncology 52(5): 427-431, 1995

Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy. Drugs 43(Suppl. 3): 23-26, 1992

Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy. Supportive Care in Cancer 8(3): 233-237, 2000

Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy. Annals of Oncology 4(Suppl. 3): 25-29, 1993

Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy--a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines. Supportive Care in Cancer 23(1): 273-282, 2015

Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. Italian Group for Antiemetic Research. Journal of Clinical Oncology 13(9): 2417-2426, 1995

Comparison of the antiemetic efficacy of tropisetron and droperidol with patient-given tramadol. Journal of International Medical Research 31(4): 267-271, 2003

A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatment. Bmc Cancer 18(1): 510, 2018

Prophylactic antiemetic efficacy of granisetron in patients with and without previous postoperative emesis. Canadian Journal of Anaesthesia 44(3): 273-277, 1997

Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy. Supportive Care in Cancer 15(4): 417-426, 2007

Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: A randomized, double-blind comparison with placebo. Canadian Journal of Anaesthesia 43(3): 226-231, 1996

Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research. Journal of Clinical Oncology 11(12): 2396-2404, 1993

Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy. International Journal of Clinical Pharmacy 40(5): 1265-1271, 2018

Antiemetic therapy with the 5 ht 3 antagonist ondansetron in cisplatin induced vomiting refractory to standard antiemetic regimens. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 523, 1990

An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Cancer Chemotherapy & Pharmacology. 33(4): 298-302, 1994